主页 /
搜索结果：“jwh 250”

“jwh 250”的搜索结果

Quick View
IPI-3063

Catalog No. A16800
Quick View

添加到收藏
selective p110δ 抑制剂

IPI-3063是一种有效的选择性p110δ抑制剂，生化IC50为2.5±1.2 nM，其他I类PI3K亚型（p110α，p110β，p110γ）的IC50值至少高400倍。了解更多

Bulk Inquiry
Quick View
PQR309 (Bimiralisib)

Catalog No. A15992
Quick View

添加到收藏
PI3K 抑制剂

PQR309是磷酸肌醇3激酶（PI3K）的口服生物利用泛抑制剂，是雷帕霉素哺乳动物靶标（mTOR）的抑制剂，具有潜在的抗肿瘤活性。了解更多

Bulk Inquiry
Quick View
AZD8186

Catalog No. A14164
Quick View

添加到收藏
PI3K 抑制剂

AZD8186是磷酸肌醇-3激酶(PI3K)β亚型的抑制剂，具有潜在的抗肿瘤活性。了解更多

Bulk Inquiry Free Sample
Quick View
VS-5584

Catalog No. A12480
Quick View

添加到收藏
PI3K/mTOR 抑制剂

VS-5584是一种新型且高度选择性的PI3K/mTOR激酶抑制剂，可用于治疗癌症。了解更多

Bulk Inquiry Free Sample
Quick View
CUDC-907 (Fimepinostat)

Catalog No. A11153
Quick View

添加到收藏
PI3K/HDAC 抑制剂

CUDC-907 (Fimepinostat)是针对PI3K和HDAC的单一小分子抑制剂，作用于PI3Kα和HDAC1/2/3/10，IC50分别为19 nM和1.7 nM/5 nM/1.8 nM/2.8 nM。了解更多

Product Citations (1)

Bulk Inquiry Free Sample
- Chie Ishikawa, .et al. The role of CUDC-907, a dual phosphoinositide-3 kinase and histone deacetylase inhibitor, in inhibiting proliferation of adult T-cell leukemia, Eur J Haematol, 2020, Eur J Haematol PMID: 32780889
Quick View
TGX-221

Catalog No. A10923
Quick View

添加到收藏
PI3K 抑制剂

TGX-221是PI3Kp110β的有效，选择性和细胞渗透性抑制剂。了解更多

Product Citations (3)

Bulk Inquiry Free Sample
- Mostafa Khater, .et al. Gβγ translocation to the Golgi apparatus activates ARF1 to spatiotemporally regulate G protein-coupled receptor signaling to MAPK, J Biol Chem, 2021, Jan-Jun, 296:100805 PMID: 34022220
- Mostafa Khater, .et al. G protein βγ translocation to the Golgi apparatus activates MAPK via p110γ-p101 heterodimers, J Biol Chem, 2021, Jan 22;296:100325 PMID: 33493514
- Pridham KJ, .et al. PIK3CB/p110β is a selective survival factor for glioblastoma, Neuro Oncol, 2018, Mar 27;20(4):494-505 PMID: 29016844
Quick View
GSK1059615

Catalog No. A10438
Quick View

添加到收藏
mTOR/PI3K 抑制剂

GSK1059615是PI3Kα (IC50 = 2 nM)的强效、可逆、ATP竞争性噻唑烷二酮抑制剂。了解更多

Product Citations (1)

Bulk Inquiry Free Sample
- Jing Xie, .et al. GSK1059615 kills head and neck squamous cell carcinoma cells possibly via activating mitochondrial programmed necrosis pathway, Oncotarget, 2017, Aug 1; 8(31): 50814-50823 PMID: 28881606
Quick View
GSK2292767

Catalog No. A16564
Quick View

添加到收藏
PI3Kδ inhibitor

GSK2292767 is a potent and selective inhibitor of phosphatidylinositol 3-kinase δ (PI3Kδ; Ki = 79 pM). GSK2292767 is >100-fold selective for PI3Kδ over a panel of 250 kinases. 了解更多

Bulk Inquiry
Quick View
Alpelisib hydrochloride

Catalog No. A21794
Quick View

添加到收藏
PI3Kα inhibitor

Alpelisib hydrochloride (BYL-719 hydrochloride) is a potent, orally active, and selective PI3Kα inhibitor with IC50s of 5 nM, 250 nM, 290 nM and 1200 nM for p110α, p110γ, p110δ, and p110β, respectively. 了解更多

Bulk Inquiry
Quick View
BYL719 (Alpelisib)

Catalog No. A11328
Quick View

添加到收藏
PI3K 抑制剂

BYL719 (Alpelisib)是一种口服生物可利用的磷脂酰肌醇3-激酶(PI3K)抑制剂，抑制 p110α/p110γ/p110δ/p110β 的 IC50 分别为 5 nM，250 nM，290 nM，1200 nM 。具有潜在的抗肿瘤活性。了解更多

Product Citations (3)

Bulk Inquiry Free Sample
- Lisann Pelzl, .et al. Antibody-mediated procoagulant platelet formation in COVID-19 is AKT dependent, J Thromb Haemost, 2022, Feb;20(2):387-398 PMID: 34752677
- J Wei, .et al. Profiling the surface proteome identifies actionable biology for TSC1 mutant cells beyond mTORC1 signaling, bioRxiv, 2018, 2018
- Pridham KJ, .et al. PIK3CB/p110β is a selective survival factor for glioblastoma, Neuro Oncol, 2018, Mar 27;20(4):494-505 PMID: 29016844